Hikma mulls buying GlaxoSmithKline assets in Egypt and Tunisia
Hikma Pharmaceuticals announced on Tuesday plans to buy GlaxoSmithKline’s stake in some assets including the drugmaker’s pharmaceutical, consumer commercialisation and manufacturing business in Egypt…
Read More...
Read More...